IDH3A and acute myeloid leukemia: Aside from the metabolic changes seen in AML-LSC regardless of AML mutational subtypes, more specific metabolic alterations are seen in AML subtypes that bear mutations in specific metabolic regulators, such as isocitrate dehydrogenases (IDH1/2) or TET2 (109).